Depression and fatigue in chronic hepatitis c patients with and without HIV co-infection

Psychosomatics

Volumn 54, Issue 5, 2013, Pages 466-471

  Tavakkoli, Mohammad ^a   Ferrando, Stephen J ^a   Rabkin, Judith ^b   Marks, Kristen ^a   Talal, Andrew H ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b New York State Psychiatric Institute ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG USE; FATIGUE; FATIGUE SEVERITY SCALE; FEMALE; HEPATITIS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIXED INFECTION; PATIENT HEALTH QUESTIONNAIRE 9; PREVALENCE;

ADULT; CASE-CONTROL STUDIES; COINFECTION; DEPRESSIVE DISORDER, MAJOR; FATIGUE; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; QUESTIONNAIRES; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84883770334     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2013.02.009     Document Type: Article

References (38)

1. 2011, World Health Organization, Geneva, WH C, Accessed June 1, 2012. http://www.who.int/mediacentre/factsheets/fs164/en/.
2. Chak E., Talal A.H., Sherman K.E., Schiff E.R., Saab S. Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int 2011, 31:1090-1101.
3. Sherman K.E., Rouster S.D., Chung R.T., Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis 2002, 34:831-837.
4. Nelligan J.A., Loftis J.M., Matthews A.M., Zucker B.L., Linke A.M., Hauser P. Depression comorbidity and antidepressant use in veterans with chronic hepatitis C: results from a retrospective chart review. J Clin Psychiatry 2008, 69:810-816.
5. Basseri B., Yamini D., Chee G., Enayati P.D., Tran T., Poordad F. Comorbidities associated with the increasing burden of hepatitis C infection. Liver Int 2010, 30:1012-1018.
6. Ferrando S.J., Evans S., Goggin K., Sewell M., Fishman B., Rabkin J. Fatigue in HIV illness: relationship to depression, physical limitations, and disability. Psychosom Med 1998, 60:759-764.
7. Dieperink E., Ho S.B., Thuras P., Willenbring M.L. A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics 2003, 44:104-112.
8. Loftis J.M., Hausera P. The phenomenology and treatment of interferon-induced depression. J Affect Disord 2004, 82:175-190.
9. Forton D.M., Allsop J.M., Main J., Foster G.R., Thomas H.C., Taylor-Robinson S.D. Evidence for a cerebral effect of the hepatitis C virus. Lancet 2001, 358:38-39.
10. Forton D.M., Taylor-Robinson S.D., Thomas H.C. Cerebral dysfunction in chronic hepatitis C infection. J Viral Hepat 2003, 10:81-86.
11. Forton D.M., Thomas H.C., Taylor-Robinson S.D. Central nervous system involvement in hepatitis C virus infection. Metab Brain Dis 2004, 19:383-391.
12. Loftis J.M., Huckans M., Ruimy S., Hinrichs D.J., Hauser P. Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha. Neurosci Lett 2008, 430:264-268.
13. Piche T., Gelsi E., Schneider S.M., Hébuterne X., Giudicelli J., Ferrua B., et al. Fatigue is associated with high circulating leptin levels in chronic hepatitis C. Gut 2002, 51(3):434-439.
14. Marcellin F., Préau M., Ravaux I., Dellamonica P., Spire B., Carrieri M.P. Self-reported fatigue and depressive symptoms as main indicators of the Quality of Life (QOL) of patients living with HIV and hepatitis C: implications for clinical management and future research. HIV Clin Trials 2007, 8:320-327.
15. Jackson C.B., Varon J., Ho A., Marks K.M., Talal A.H., Kreek M.J. Identification of substance use and dependence among patients with viral hepatitis. Dig Liver Dis 2010, 42:650-656. 2010, Sept; 42.
16. Wulsin L., Somoza E., Heck J. The feasibility of using the Spanish PHQ-9 to screen for depression in primary care in Honduras. Prim Care Companion J Clin Psychiatry 2002, 4:191-195.
17. Watnick S., Wang P.-L., Demadura T., Ganzini L. Validation of 2 depression screening tools in dialysis patients. Am J Kidney Dis 2005, 46:919-924.
18. Williams L.S., Brizendine E.J., Plue L., Bakas T., Tu W., Hendrie H., et al. Performance of the PHQ-9 as a screening tool for depression after stroke. Stroke 2005, 36:635-638.
19. Huang F.Y., Chung H., Kroenke K., Delucchi K.L., Spitzer R.L. Using the patient Health Questionnaire-9 to measure depression among racially and ethnically diverse primary Care patients. J Gen Intern Med 2006, 21:547-552.
20. Arroll B., Goodyear-Smith F., Crengle S., Gunn J., Kerse N., Fishman T., et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med 2010, 8:348-353.
21. Löwe B., Schenkel I., Carney-Doebbeling C., Göb C. Responsiveness of the PHQ-9 to psychopharmacological depression treatment. Psychosomatics 2006, 47:62-67.
22. Hewlett S., Dures E., Almeida C. Measures of fatigue: bristol Rheumatoid Arthritis fatigue Multi-Dimensional Questionnaire (BRAF MDQ), bristol Rheumatoid Arthritis fatigue numerical Rating Scales (BRAF NRS) for severity, effect, and coping, chalder Fatigue Questionnaire (CFQ), checklist individual strength (CIS20R and CIS8R), fatigue Severity Scale (FSS), functional assessment chronic illness therapy (fatigue) (FACIT-F), multi-dimensional assessment of fatigue (MAF), Multi-Dimensional Fatigue Inventory (MFI), pediatric Quality Of Life (PedsQL) Multi-Dimensional Fatigue Scale, profile of fatigue (ProF), short form 36 vitality subscale (SF-36 VT), and visual Analog Scales (VAS). Arthritis Care Res (Hoboken) 2011, 63(Suppl 11):S263-S286.
23. Kleinman L., Zodet M.W., Hakim Z., Aledort J., Barker C., Chan K., et al. Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C. Qual Life Res 2000, 9:499-508.
24. Rabkin J.G., McElhiney M.C., Rabkin R., McGrath P.J. Modafinil treatment for fatigue in HIV/AIDS: a randomized placebo-controlled study. J Clin Psychiatry 2010, 71:707-715.
25. Chou R., Clark E.C., Helfand M. Screening for hepatitis C virus infection: a review of the evidence for the U.S. Preventive Services Tasks Force Ann Intern Med 2004, 140:465-479.
26. Jou J.H., Muir A.J. In the clinic. Hepat C Ann Intern Med 2008, 148. ITC61-ITC6-16.
27. Saillour F., Dabis F., Dupon M., Lacoste D., Trimoulet P., Rispal P., et al. Prevalence and determinants of antibodies to hepatitis C virus and markers for hepatitis B virus infection in patients with HIV infection in Aquitaine. Groupe Epidémiologie Clinique Sida Aquitaine Bmj 1996, 313:461-464.
28. El-Serag H.B. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012, 142:1264-1273.
29. Goh J., Coughlan B., Quinn J., O'Keane J.C., Crowe J. Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection. Eur J Gastroenterol Hepatol 1999, 11:833-838.
30. Wessely S., Pariante C. Fatigue, depression and chronic hepatitis C infection. Psychol Med 2002, 32:1-10.
31. Poynard T., Cacoub P., Ratziu V., Myers R.P., Dezailles M.H., Mercadier A., et al. Fatigue in patients with chronic hepatitis C. J Viral Hepat 2002, 9:295-303.
32. Bonaccorso S., Marino V., Biondi M., Grimaldi F., Ippoliti F., Maes M. Depression induced by treatment with interferon-α in patients affected by hepatitis C virus. J Affect Disord 2002, 72:237-241.
33. Schaefer M., Schmidt F., Folwaczny C., Lorenz R., Martin G., Schindlbeck N., et al. Adherence and mental side effects during hepatitis C treatment with interferon-α and ribavirin in psychiatric risk groups. Hepatology 2003, 37:443-451.
34. Crone C.C., Gabriel G.M., Wise T.N. Managing the neuropsychiatric side effects of interferon-based therapy for hepatitis C. Cleve Clin J Med 2004, 71(Suppl 3):S27-S32.
35. Pappin M., Wouters E., Booysen F.L. Anxiety and depression amongst patients enrolled in a public sector antiretroviral treatment programme in South Africa: a cross-sectional study. BMC Public Health 2012, 12.
36. Rao D., Chen W.T., Pearson C.R., Simoni J.M., Fredriksen-Goldsen K., Nelson K., et al. Social support mediates the relationship between HIV stigma and depression/quality of life among people living with HIV in Beijing, China. Int J STD AIDS 2012, 23:481-484.
37. Brienza R.S., Stein M.D., Chen M.-H., Gogineni A., Sobota M., Maksad J., et al. Depression among needle exchange program and methadone maintenance clients. J Subst Abus Treat 2000, 18:331-337.
38. Havard A., Teesson M., Darke S., Ross J. Depression among heroin users: 12-month outcomes from the Australian Treatment Outcome Study (ATOS). J Subst Abuse Treat 2006, 30:355-362.